GB virus C (GBV-C) infection in hepatitis C virus (HCV) seropositive women with or at risk for HIV infection e114467
PLoS ONE, ISSN: 1932-6203, Vol: 9, Issue: 12, Page: e114467
2014
- 8Citations
- 40Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations8
- Citation Indexes8
- CrossRef7
- Captures40
- Readers40
- 40
Article Description
Results: 438 hepatitis C virus (HCV) seropositive women, including 306 HIVinfected and 132 HIV-uninfected women, from the HIV Epidemiologic Research Study were evaluated for GBV-C RNA. 347 (79.2%) women were GBV-C RNA negative, while 91 (20.8%) were GBV-C RNA positive. GBV-C positive women were younger than GBV-C negative women. Among 306 HIV-infected women, 70 (22.9%) women were HIV/GBV-C co-infected. Among HIV-infected women, the only significant difference between GBV-negative and GBV-positive women was age (mean 38.4 vs. 35.1 years; p<0.001). Median baseline CD4 cell counts and plasma HIV RNA levels were similar. The GBV-C genotypes were 1 (n531; 44.3%), 2 (n536; 51.4%), and 3 (n53; 4.3%). The distribution of GBV-C genotypes in coinfected women differed significantly by race/ethnicity. However, median CD4 cell counts and log10 HIV RNA levels did not differ by GBV-C genotype. GBV-C incidence was 2.7% over a median follow-up of 2.9 (IQR: 1.5, 4.9) years, while GBV-C clearance was 35.7% over a median follow-up of 2.44 (1.4, 3.5) years. 4 women switched genotypes. Background: GB virus C (GBV-C) may have a beneficial impact on HIV disease progression; however, the epidemiologic characteristics of this virus are not well characterized. Behavioral factors and gender may lead to differential rates of GBVC infection; yet, studies have rarely addressed GBV-C infections in women or racial/ethnic minorities. Therefore, we evaluated GBV-C RNA prevalence and genotype distribution in a large prospective study of high-risk women in the US. Conclusions: Age, injection drug use, a history of sex for money or drugs, and number of recent male sex partners were associated with GBV-C infection among all women in this analysis. However, CD4 cell count and HIV viral load of HIV/HCV/ GBV-C co-infected women were not different although race was associated with GBV-C genotype.
Bibliographic Details
10.1371/journal.pone.0114467; 10.3410/f.725272622.793502518; 10.1371/journal.pone.0114467.t003; 10.1371/journal.pone.0114467.g001; 10.1371/journal.pone.0114467.t002; 10.1371/journal.pone.0114467.t001
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84916624832&origin=inward; http://dx.doi.org/10.1371/journal.pone.0114467; http://www.ncbi.nlm.nih.gov/pubmed/25493916; https://facultyopinions.com/prime/725272622#eval793502518; http://dx.doi.org/10.3410/f.725272622.793502518; https://dx.plos.org/10.1371/journal.pone.0114467.t003; http://dx.doi.org/10.1371/journal.pone.0114467.t003; https://dx.plos.org/10.1371/journal.pone.0114467; https://dx.plos.org/10.1371/journal.pone.0114467.g001; http://dx.doi.org/10.1371/journal.pone.0114467.g001; https://dx.plos.org/10.1371/journal.pone.0114467.t002; http://dx.doi.org/10.1371/journal.pone.0114467.t002; https://dx.plos.org/10.1371/journal.pone.0114467.t001; http://dx.doi.org/10.1371/journal.pone.0114467.t001; https://dx.doi.org/10.1371/journal.pone.0114467.t003; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0114467.t003; https://dx.doi.org/10.1371/journal.pone.0114467.t002; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0114467.t002; https://dx.doi.org/10.1371/journal.pone.0114467; https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0114467; https://dx.doi.org/10.1371/journal.pone.0114467.g001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0114467.g001; https://dx.doi.org/10.1371/journal.pone.0114467.t001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0114467.t001; http://dx.plos.org/10.1371/journal.pone.0114467.t001; http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0114467; https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0114467&type=printable; http://dx.plos.org/10.1371/journal.pone.0114467.t003; http://www.plosone.org/article/metrics/info:doi/10.1371/journal.pone.0114467; http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0114467&type=printable; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0114467; http://dx.plos.org/10.1371/journal.pone.0114467.t002; http://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0114467; http://dx.plos.org/10.1371/journal.pone.0114467; http://f1000.com/prime/725272622#eval793502518; http://dx.plos.org/10.1371/journal.pone.0114467.g001
Faculty Opinions Ltd
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know